This activity has been designed to meet the educational needs of physicians, nurse practitioners (NPs), physician assistants (PAs), and other healthcare professionals who are currently managing and treating patients with nonalcoholic steatohepatitis (NASH).
Upon completion of this activity, participants should be able to:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Chronic Liver Disease Foundation. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
All additional planning committee members, the University of Cincinnati staff and the Chronic Liver Disease Foundation staff have no relationships to disclose.
Learner Assurance Statement
The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees' professional development.
Off-Label Disclosure Statement
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
AMERICANS WITH DISABILITIES ACT:
The event staff will be glad to assist you with any special needs (ie, physical, dietary). Please contact us prior to the event at 1- 888-565-5321.
Grant Support Info Statement
Supported by educational grant from Siemens Healthcare Diagnostics, Inc.
Robert Wong, MD, MS is a Clinical Associate Professor of Medicine (Affiliated) in the Division of Gastroenterology and Hepatology, Stanford University School of Medicine, and staff physician in the Gastroenterology and Hepatology Section at Veterans Affairs Palo Alto Healthcare System. He graduated from University of California, San Francisco School of Medicine, completed internal medicine residency at California Pacific Medical Center and gastroenterology and hepatology fellowship at Stanford University School of Medicine, where he also completed a Masterâ€™s in Epidemiology and Clinical Research. He is a Fellow of the American College of Gastroenterology and is actively involved with the American College of Gastroenterology and the American Association for the Study of Liver Diseases committees. His clinical interests include the management of patients with complex liver diseases, including viral hepatitis, hepatocellular carcinoma, and nonalcoholic fatty liver disease. His research focuses on epidemiology and outcomes in patients with chronic liver disease and healthcare disparities among under-served minority and vulnerable populations.
Research/Consultant: Gilead Sciences, Inc.